Join the 200th Anniversary Celebration

Original Article

Brief Report

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation

Boulos-Paul Bejjani, M.D., Philippe Damier, M.D., Ph.D., Isabelle Arnulf, M.D., Lionel Thivard, M.D., Anne-Marie Bonnet, M.D., Didier Dormont, M.D., Philippe Cornu, M.D., Bernard Pidoux, M.D., Ph.D., Yves Samson, M.D., and Yves Agid, M.D., Ph.D.

N Engl J Med 1999; 340:1476-1480May 13, 1999

Article

Continuous high-frequency stimulation of the basal ganglia was recently introduced for the treatment of patients with advanced Parkinson's disease.1 This treatment seems to be most effective when the electrodes are placed in the subthalamic nuclei.2,3 Among the 20 patients treated successfully by bilateral subthalamic stimulation at our center, 1 woman had transient acute depression when high-frequency stimulation was delivered to the left substantia nigra, 2 mm below the site where stimulation alleviated the signs of Parkinson's disease. We describe here the results of detailed studies of the induction of major, reversible depression in this woman.

Case Report

A 65-year-old right-handed woman with a 30-year history of Parkinson's disease, who had severe rigidity, severe akinesia, and moderate tremor while resting, despite treatment with 900 mg of levodopa, 2.5 mg of pergolide, and 3 to 5 mg of lorazepam daily, and disabling dyskinesias induced by levodopa underwent bilateral implantation of electrodes in the region of the subthalamic nuclei for stimulation therapy. She had no history of psychiatric disorders or depression, even after the onset of Parkinson's disease, nor had she had mood fluctuations while she was receiving levodopa. The quadripolar electrodes implanted under stereotactic guidance3 were connected by a cable under the scalp extending to a programmable pulse generator placed under the skin in the subclavicular area, like a cardiac pacemaker. Each electrode had four contacts numbered 0 to 3 from bottom to top, over a length of 7.5 mm, permitting a choice of the most effective sites of stimulation in the target region.

To identify the optimal site, the effect of stimulation through each of the four contacts of each electrode was evaluated 10 days after surgery and 12 hours after the most recent dose of levodopa, according to our standardized protocol.3 Briefly, the voltage for stimulation was increased in increments of 0.1 V, from 0 to 5 V, with a five-minute plateau after every additional 0.5 V, until a satisfactory reduction in symptoms of Parkinson's disease was obtained or an adverse effect, such as dysarthria, dystonic contraction, or paresthesia,2,4 occurred. In most patients, stimulation through one or two contacts of each electrode improves parkinsonian symptoms, whereas stimulation through the other contacts has no effect or has adverse effects.

During this postoperative evaluation, the patient's face expressed profound sadness within five seconds after a continuous monopolar 2.4-V rectangular current with a pulse width of 60 μsec and a frequency of 130 Hz was delivered for seven minutes through contact 0 of the electrode implanted on the left. Although still alert, the patient leaned to the right, started to cry, and verbally communicated feelings of sadness, guilt, uselessness, and hopelessness (Figure 1AFigure 1Videotaped Images of the Patient's Facial Expressions during Depression Elicited by High-Frequency Stimulation through an Electrode Implanted in the Left Subthalamic Region for Treatment of Parkinson's Disease., Figure 1B, Figure 1C, and Figure 1D), such as “I'm falling down in my head, I no longer wish to live, to see anything, hear anything, feel anything. . . .” When asked why she was crying and if she felt pain, she responded: “No, I'm fed up with life, I've had enough. . . . I don't want to live any more, I'm disgusted with life. . . . Everything is useless, always feeling worthless, I'm scared in this world.” When asked why she was sad, she replied: “I'm tired. I want to hide in a corner. . . . I'm crying over myself, of course. . . . I'm hopeless, why am I bothering you. . . .” She had no hallucinations, nor were there any changes in her motor or cognitive symptoms of Parkinson's disease. The depression disappeared less than 90 seconds after stimulation was stopped. For the next five minutes the patient was in a slightly hypomanic state, and she laughed and joked with the examiner, playfully pulling his tie. She recalled the entire episode. Stimulation, performed at least twice, through the other contacts of each electrode did not elicit this psychiatric response.

Unlike stimulation through contact 0 of the electrode on the left, stimulation through upper contacts 1 and 2 of the left electrode and contact 2 of the right electrode reduced the motor symptoms of Parkinson's disease on the contralateral side. The patient was therefore treated with continuous bilateral stimulation through contacts 1 and 2 of the left electrode (2.4 V; pulse width, 60 μsec; frequency, 130 Hz) and contact 2 of the right electrode (2.6 V; pulse width, 60 μsec; frequency, 185 Hz). This treatment was sufficiently effective that drug therapy was discontinued one month after surgery. During treatment, the patient's score for dyskinesia dropped from 9 to 0 (range of possible scores, 0 to 13), and her score for motor fluctuation dropped from 5 to 0 (range, 0 to 7), as measured by parts IVA and IVB, respectively, of the Unified Parkinson's Disease Rating Scale,5 a scale in which the highest score indicates the most severe disability, and 0 indicates no disability.

Results

Stimulation through contact 0 of the left electrode was repeated twice on two successive days (20 and 21 days after surgery) to verify the reproducibility of the depressive episode. Informed written consent was obtained from the patient for the study, and the procedure was recorded on videotape. Stimulation was performed in the same manner as during the original episode, after both the left and the right electrodes had been turned off for one hour. On the first day, stimulation was performed 12 hours after the most recent dose of levodopa. On the second day, a 200-mg dose of levodopa was administered one hour before the study to obtain maximal improvement of motor signs. The patient was not aware of whether the stimulation was real or simulated.

On the first day, after bilateral stimulation was stopped, the patient's parkinsonian symptoms increased (the score on part III of the Unified Parkinson's Disease Rating Scale rose from 10 to 35 on a scale of 0 to 108), but her mood did not change. When current was applied through contact 0 of the left electrode, the patient's facial expression changed within a few seconds and she became extremely depressed, as she had during stimulation through the same contact 10 days after surgery. When stimulation was stopped, the patient's mood returned to normal within one minute. The next day, after motor improvement in response to levodopa (the score on part III of the Unified Parkinson's Disease Rating Scale was 15), stimulation through contact 0 of the left electrode again elicited symptoms of depression without altering the parkinsonian symptoms; at this time the patient was agitated instead of akinetic, she cried more, and she moved her arms and head more than on the previous day. Simulated onset or cessation of stimulation had no effect on the patient.

The positions of the contacts of the electrode were determined on magnetic resonance images with the help of the Schaltenbrand and Wharen atlas.6,7 Contact 0 of the left electrode was located in the central substantia nigra, including part of the pars compacta and pars reticulata (Figure 2AFigure 2Anatomical Localization of Left Contact 0, through Which Stimulation Induced Depression (Panel A), and Left Contact 2, through Which Stimulation Improved the Motor Symptoms of Parkinson's Disease (Panel B).). Contacts 1 and 2 of the left electrode, used for continuous antiparkinsonian therapy, were located in the subthalamic nucleus (Figure 2B).

Eight months after surgery, two hours after stimulation was turned off, positron-emission tomography with oxygen-15–labeled water was performed (ECAT-HR+, Siemens, Erlangen, Germany).8 Five images were recorded after five minutes of stimulation through contact 0 of the left electrode, and five more images were recorded eight minutes after stimulation was stopped, in a randomized fashion, with the patient unaware of whether the stimulation was real or simulated. Data were analyzed with the statistical mapping program SPM 96 (Wellcome Department of Cognitive Neurology, London).9 During stimulation, the patient noted both acute sadness, although less severe than during previous sessions, and the sensation that her body was being sucked into a black hole. This illusion of bodily motion was not accompanied by hallucinations or confusion. A significant increase in blood flow was detected in the right parietal lobe, in the left orbitofrontal cortex, in the left globus pallidus, and also in the left amygdala and anterior thalamus (Figure 3Figure 3Brain Regions Activated during an Acute Episode of Depression Induced by High-Frequency Stimulation of the Left Substantia Nigra.).

None of the other 19 patients treated by subthalamic stimulation at our center had symptoms of depression during the systematic postoperative evaluation of the effect of stimulation through each contact of the electrodes.

Discussion

The syndrome elicited in this patient by stimulation of the left substantia nigra fulfilled most of the nine criteria for major depression, as defined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders 10: profound sadness, feelings of emptiness and worthlessness, markedly diminished interest and pleasure, agitation (with levodopa) or inhibition (without levodopa), fatigue, decreased concentration, inappropriate guilt, and a morbid interest in death. The other two criteria — weight change and sleep disorder — would not be applicable to short episodes, such as those elicited in this case. The symptoms could not be explained by pain or an increase in the severity of the parkinsonian symptoms. The depression, which was selectively caused by stimulation through contact 0 of the left electrode, was independent of the patient's motor symptoms and of levodopa therapy; stimulation-dependent, beginning abruptly when stimulation started and resolving within one minute after stimulation ceased; reproducible; and not induced by simulated stimulation.

Contact 0 of the left electrode was located in the central part of the substantia nigra, 2 mm below contacts 1 and 2, which were in the subthalamic nucleus. When the subthalamic nucleus was stimulated, the symptoms of Parkinson's disease improved, but the patient's mood was not altered. Since stimulation is considered to affect only a few cubic millimeters of neural tissue,1,2 the depression probably resulted from the stimulation of afferent, efferent, or passing fibers within the substantia nigra or from the inhibition of these fibers; the effects of high-frequency thalamic1 or subthalamic2 stimulation are similar to those of thalamotomy in humans or subthalamotomy in nonhuman primates.11

The neural networks involved in this particular case have not been clearly identified, although neurons containing norepinephrine, serotonin, and dopamine and neurotransmitters suspected to be involved in depression12 are present in the substantia nigra. Medial noradrenergic bundles and serotoninergic fibers from the dorsal raphe nucleus can be ruled out because of their distance from the site of stimulation. Decreased dopaminergic neurotransmission, thought to have a role in the depression associated with Parkinson's disease,13 is unlikely to have been responsible, for two reasons. First, contact 0 of the left electrode could not have affected projections from dopaminergic neurons dorsal to the subthalamic nucleus, because they were too far from the area of stimulation. Second, the patient was not depressed when her parkinsonism was severe (i.e., when dopamine concentrations in the striatum would have been at their lowest) or when it was maximally improved by levodopa. Stimulation may have affected the activity of nigral γ-aminobutyric acid–employing (GABAergic) neurons innervating the ventral nuclei of the thalamus,14 which project to the prefrontal and orbitofrontal cortexes.15 Dysfunction of these systems has been implicated in mood disorders16,17 and in self-induced sadness in normal subjects.18 Lesions of the left basal ganglia are associated with depression in patients who have had strokes.19,20

The results of positron-emission tomography revealed activation of the left orbitofrontal cortex, a finding consistent with involvement of the nigrothalamic pathway, which extends to the left amygdala and limbic structures and is implicated in the processing of unpleasant feelings.21,22 Activation of the left pallidum may result from retrograde stimulation of GABAergic projections from the external pallidum to the substantia nigra.23 The reason the right inferior parietal lobe was activated is not known but may be related to the patient's sensation of motion, since this brain region contains “maps” used to orient bodily movement in space.24

The fact that depression was not elicited by stimulation of the right side in this patient or by stimulation of any sort in the other patients might be explained by differences in the anatomy of the subthalamic region, or by differences in the placement of the electrodes. Stimulation of a restricted site in the upper midbrain can cause acute major depression, and our findings provide a basis for further studies to elucidate the neural networks involved in depression.

We are indebted to Dr. Savas Papadopoulos for his participation in the clinical study; to Drs. David Gervais, Jerome Yelnik, and Chantal François for their assistance with the anatomical localizations; to Dr. Jean-Baptiste Poline for positron-emission tomography; and to Dr. Merle Ruberg for her careful review of the manuscript.

Source Information

From the Centre d'Investigation Clinique, Fédération de Neurologie and INSERM Unité 289 (B.-P.B., P.D., I.A., A.-M.B., Y.A.), Service de Neuroradiologie (D.D.), Service de Neurochirurgie (P.C.), and Service d'Explorations Fonctionnelles Neurologiques (B.P.), Groupe Hospitalier Pitié–Salpêtrière, Paris; and the Service Hospitalier Frederic Joliot, Commissariat à l'Energie Atomique, Orsay, France (L.T., Y.S.).

Address reprint requests to Dr. Bejjani at the Centre d'Investigation Clinique, Hôpital Pitié–Salpêtrière, 47 Blvd. de l'Hôpital, 75651 Paris CEDEX 13, France, or at .

References

References

  1. 1

    Benabid AL, Pollak P, Gervason CL, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406
    CrossRef | Web of Science | Medline

  2. 2

    Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95
    CrossRef | Web of Science | Medline

  3. 3

    Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease: two targets? Neurology 1997;49:1564-1569
    Web of Science | Medline

  4. 4

    Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855
    Web of Science | Medline

  5. 5

    Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. 2nd ed. Florham Park, N.J.: MacMillan Healthcare Information, 1987:153-63.

  6. 6

    Dormont D, Zerah M, Cornu P, et al. A technique of measuring the precision of an MR-guided stereotaxic installation using anatomic specimens. AJNR Am J Neuroradiol 1994;15:365-371
    Web of Science | Medline

  7. 7

    Schaltenbrand G, Wharen W. Atlas for stereotaxy of the human brain. Stuttgart, Germany: Georg Thieme, 1977.

  8. 8

    Fox PT, Mintun MA, Raichle ME, Herscovitch P. A noninvasive approach to quantitative functional brain mapping with H215O and positron emission tomography. J Cereb Blood Flow Metab 1984;4:329-333
    CrossRef | Web of Science | Medline

  9. 9

    Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric mapping in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210
    CrossRef

  10. 10

    Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.

  11. 11

    Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438
    CrossRef | Web of Science | Medline

  12. 12

    Potter WZ, Rudorfer MV, Manji H. The pharmacologic treatment of depression. N Engl J Med 1991;325:633-642
    Full Text | Web of Science | Medline

  13. 13

    Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 1995;65:49-60
    Medline

  14. 14

    Ilinsky IA, Jouandet ML, Goldman-Rakic PS. Organization of the nigrothalamocortical system in the rhesus monkey. J Comp Neurol 1985;236:315-330
    CrossRef | Web of Science | Medline

  15. 15

    Goldman-Rakic PS, Porrino LJ. The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985;242:535-560
    CrossRef | Web of Science | Medline

  16. 16

    Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827
    CrossRef | Web of Science | Medline

  17. 17

    Fischer H, Andersson JL, Furmark T, Fredrikson M. Brain correlates of an unexpected panic attack: a human positron emission tomographic study. Neurosci Lett 1998;251:137-140
    CrossRef | Web of Science | Medline

  18. 18

    Pardo JV, Pardo PJ, Raichle ME. Neural correlates of self-induced dysphoria. Am J Psychiatry 1993;150:713-719
    Web of Science | Medline

  19. 19

    Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93
    CrossRef | Web of Science | Medline

  20. 20

    Herrmann M, Bartels C, Schumacher M, Wallesch CW. Poststroke depression: is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke 1995;26:850-856
    CrossRef | Web of Science | Medline

  21. 21

    Zald DH, Pardo JV. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation. Proc Natl Acad Sci U S A 1997;94:4119-4124
    CrossRef | Web of Science | Medline

  22. 22

    Adolphs R, Tranel D, Damasio H, Damasio AR. Fear and the human amygdala. J Neurosci 1995;15:5879-5891
    Web of Science | Medline

  23. 23

    Bevan MD, Smith AD, Bolam JP. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience 1996;75:5-12
    CrossRef | Web of Science | Medline

  24. 24

    Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J. Knowing where and getting there: a human navigation network. Science 1998;280:921-924
    CrossRef | Web of Science | Medline

Citing Articles (187)

Citing Articles

  1. 1

    Verena Eveline Rozanski, Martin Lieb, Christian Vollmar, Jan-Hinnerk Mehrkens, Kai Bötzel. (2012) Evidence of a non-motor microlesion effect following deep brain surgery: a case report. Acta Neurochirurgica
    CrossRef

  2. 2

    Sylvia Navailles, Philippe Deurwaerdère. (2012) Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease. Molecular Neurobiology
    CrossRef

  3. 3

    Dag Aarsland, Sven Påhlhagen, Clive G. Ballard, Uwe Ehrt, Per Svenningsson. (2011) Depression in Parkinson disease—epidemiology, mechanisms and management. Nature Reviews Neurology 8:1, 35-47
    CrossRef

  4. 4

    Amorn Wongsarnpigoon, Warren M Grill. (2011) Effects of stimulation parameters and electrode location on thresholds for epidural stimulation of cat motor cortex. Journal of Neural Engineering 8:6, 066016
    CrossRef

  5. 5

    F Benedetti, E Carlino, A Pollo. (2011) Hidden Administration of Drugs. Clinical Pharmacology & Therapeutics 90:5, 651-661
    CrossRef

  6. 6

    Volker A. Coenen, Thomas E. Schlaepfer, Burkhard Maedler, Jaak Panksepp. (2011) Cross-species affective functions of the medial forebrain bundle—Implications for the treatment of affective pain and depression in humans. Neuroscience & Biobehavioral Reviews 35:9, 1971-1981
    CrossRef

  7. 7

    Sonny K.H. Tan, Marcus L.F. Janssen, Ali Jahanshahi, Leonidas Chouliaras, Veerle Visser-Vandewalle, Lee Wei Lim, Harry W.M. Steinbusch, Trevor Sharp, Yasin Temel. (2011) High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions. Journal of Psychiatric Research 45:10, 1307-1315
    CrossRef

  8. 8

    RICKARD L. SJÖBERG, PATRIC BLOMSTEDT. (2011) The psychological neuroscience of depression: Implications for understanding effects of deep brain stimulation. Scandinavian Journal of Psychology 52:5, 411-419
    CrossRef

  9. 9

    Yoland Smith, Thomas Wichmann, Stewart A Factor, Mahlon R DeLong. (2011) Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa. Neuropsychopharmacology
    CrossRef

  10. 10

    L. Schilbach, P. H. Weiss, J. Kuhn, L. Timmermann, J. Klosterkötter, W. Huff. (2011) Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits. Neurocase1-8
    CrossRef

  11. 11

    Lars Wojtecki, Lars Timmermann, Stefan Jun Groiss, Saskia Elben, Christiane Reck, Martin Südmeyer, Volker Sturm, Alfons Schnitzler. (2011) Long-term time course of affective lability after subthalamic deep brain stimulation electrode implantation. Neurocase1-6
    CrossRef

  12. 12

    Sonny K.H. Tan, Henrike Hartung, Trevor Sharp, Yasin Temel. (2011) Serotonin-dependent depression in Parkinson’s disease: A role for the subthalamic nucleus?. Neuropharmacology 61:3, 387-399
    CrossRef

  13. 13

    Stéphane Thobois, Emmanuel Broussolle. (2011) PET functional imaging of deep brain stimulation in Parkinson’s disease. Journal of Neurolinguistics
    CrossRef

  14. 14

    P. Shotbolt, J. Moriarty, A. Costello, A. Jha, A. David, K. Ashkan, M. Samuel. (2011) Relationships between deep brain stimulation and impulse control disorders in Parkinson’s disease, with a literature review. Parkinsonism & Related Disorders
    CrossRef

  15. 15

    D. Huys, M. Möller, E.-H. Kim, K. Hardenacke, W. Huff, J. Klosterkötter, L. Timmermann, C. Woopen, J. Kuhn. (2011) Die tiefe Hirnstimulation bei psychiatrischen Erkrankungen. Der Nervenarzt
    CrossRef

  16. 16

    Tiffini Voss, Irene Hegeman Richard. 2011. Depression in Parkinson's Disease. , 183-192.
    CrossRef

  17. 17

    Brian J. Snyder, Andres M. Lozano. 2011. Surgery for Non-Dopaminergic and Non-Motor Features of Parkinson's Disease. , 409-415.
    CrossRef

  18. 18

    Christian Even, Daniel Weintraub. (2011) Is depression in Parkinson's Disease (PD) a specific entity?. Journal of Affective Disorders
    CrossRef

  19. 19

    Thomas Wichmann, Mahlon R. DeLong. (2011) Deep-brain stimulation for basal ganglia disorders. Basal Ganglia 1:2, 65-77
    CrossRef

  20. 20

    Nadia González-García, Jorge L. Armony, Julian Soto, David Trejo, Marco A. Alegría, René Drucker-Colín. (2011) Effects of rTMS on Parkinson’s disease: a longitudinal fMRI study. Journal of Neurology 258:7, 1268-1280
    CrossRef

  21. 21

    Amorn Wongsarnpigoon, Warren M. Grill. (2011) Computer-based model of epidural motor cortex stimulation: Effects of electrode position and geometry on activation of cortical neurons. Clinical Neurophysiology
    CrossRef

  22. 22

    Masayuki Watanabe, Douglas P. Munoz. (2011) Probing basal ganglia functions by saccade eye movements. European Journal of Neuroscience 33:11, 2070-2090
    CrossRef

  23. 23

    Daniel Weiss, Sorin Breit, Tobias Wächter, Christian Plewnia, Alireza Gharabaghi, Rejko Krüger. (2011) Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson’s disease. Journal of Neurology 258:6, 1183-1185
    CrossRef

  24. 24

    Jessica Zonana, Matthew Zimmerman, Sarah Schur McCarty, Stephen Ferrando. (2011) A Case of Abrupt-Onset Apathy, Psychosis, and Depression Following Deep Brain Stimulation in a Patient with Parkinson's Disease. Psychosomatics
    CrossRef

  25. 25

    Sharon Norman, Ravi Bellamkonda. 2011. MEMS in the Nervous System. .
    CrossRef

  26. 26

    Karsten Witt, Jens Kuhn, Lars Timmermann, Mateusz Zurowski, Christiane Woopen. (2011) Deep Brain Stimulation and the Search for Identity. Neuroethics
    CrossRef

  27. 27

    Stanley Fahn, Joseph Jankovic, Mark Hallett. 2011. Nonmotor problems in Parkinson disease. , 183-196.
    CrossRef

  28. 28

    Claudio L. Bassetti. (2011) Nonmotor Disturbances in Parkinson’s Disease. Neurodegenerative Diseases 8:3, 95-108
    CrossRef

  29. 29

    Ihtsham U. Haq, Kelly D. Foote, Wayne G. Goodman, Samuel S. Wu, Atchar Sudhyadhom, Nicola Ricciuti, Mustafa S. Siddiqui, Dawn Bowers, Charles E. Jacobson, Herbert Ward, Michael S. Okun. (2011) Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. NeuroImage 54, S247-S255
    CrossRef

  30. 30

    Stanley Fahn, Joseph Jankovic, Mark Hallett. 2011. Surgical treatment of Parkinson disease and other movement disorders. , 157-182.
    CrossRef

  31. 31

    Tessel Boertien, Ludvic Zrinzo, Joshua Kahan, Marjan Jahanshahi, Marwan Hariz, Laura Mancini, Patricia Limousin, Thomas Foltynie. (2011) Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease. Movement Disordersn/a-n/a
    CrossRef

  32. 32

    Henk Groenewegen, Harry Uylings. (2010) Het enigma van de nucleus subthalamicus: implicaties voor neurologische en psychiatrische ziektebeelden. Neuropraxis 2010:6, 184-191
    CrossRef

  33. 33

    Sonny KH Tan, Rinske Vlamings, LeeWei Lim, Thibault Sesia, Marcus LF Janssen, Harry WM Steinbusch, Veerle Visser-Vandewalle, Yasin Temel. (2010) Experimental Deep Brain Stimulation in Animal Models. Neurosurgery 67:4, 1073-1080
    CrossRef

  34. 34

    Morten L. Kringelbach, Alexander L. Green, Sarah L. F. Owen, Patrick M. Schweder, Tipu Z. Aziz. (2010) Sing the mind electric - principles of deep brain stimulation. European Journal of Neuroscience 32:7, 1070-1079
    CrossRef

  35. 35

    Paul Krack, Marwan I. Hariz, Christelle Baunez, Jorge Guridi, Jose A. Obeso. (2010) Deep brain stimulation: from neurology to psychiatry?. Trends in Neurosciences 33:10, 474-484
    CrossRef

  36. 36

    Christoph J. Griessenauer, Su-Youne Chang, Susannah J. Tye, Christopher J. Kimble, Kevin E. Bennet, Paul A. Garris, Kendall H. Lee. (2010) Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry—a proof-of-principle study. Journal of Neurosurgery 113:3, 656-665
    CrossRef

  37. 37

    Julie Regan, Margaret Walshe, W. Oliver Tobin. (2010) Immediate Effects of Thermal–Tactile Stimulation on Timing of Swallow in Idiopathic Parkinson’s Disease. Dysphagia 25:3, 207-215
    CrossRef

  38. 38

    2010. References. , 335-393.
    CrossRef

  39. 39

    Jens Volkmann, Christine Daniels, Karsten Witt. (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nature Reviews Neurology
    CrossRef

  40. 40

    T.E. Schläpfer, S. Kayser. (2010) Die Entwicklung der tiefen Hirnstimulation bei der Behandlung therapieresistenter psychiatrischer Erkrankungen. Der Nervenarzt 81:6, 696-701
    CrossRef

  41. 41

    J. Herzog, G. Deuschl. (2010) Tiefe Hirnstimulation bei der Parkinson-Krankheit. Der Nervenarzt 81:6, 669-679
    CrossRef

  42. 42

    Takashi Morishita, Kelly D. Foote, Adam P. Burdick, Yoichi Katayama, Takamitsu Yamamoto, Steven J. Frucht, Michael S. Okun. (2010) Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies. Parkinsonism & Related Disorders 16:3, 153-162
    CrossRef

  43. 43

    Thomas Wichmann, Mahlon R. DeLong. 2010. Deep-Brain Stimulation for Neurologic and Psychiatric Disorders. , 659-681.
    CrossRef

  44. 44

    D. Dormont, D. Seidenwurm, D. Galanaud, P. Cornu, J. Yelnik, E. Bardinet. (2010) Neuroimaging and Deep Brain Stimulation. American Journal of Neuroradiology 31:1, 15-23
    CrossRef

  45. 45

    Erik Ch. Wolters. (2009) Non-motor extranigral signs and symptoms in Parkinson's disease. Parkinsonism & Related Disorders 15, S6-S12
    CrossRef

  46. 46

    Benedicte Ballanger, Marjan Jahanshahi, Emmanuel Broussolle, Stéphane Thobois. (2009) PET functional imaging of deep brain stimulation in movement disorders and psychiatry. Journal of Cerebral Blood Flow & Metabolism 29:11, 1743-1754
    CrossRef

  47. 47

    Andre Machado, Suzanne Haber, Nathaniel Sears, Benjamin Greenberg, Donald Malone, Ali Rezai. (2009) Functional topography of the ventral striatum and anterior limb of the internal capsule determined by electrical stimulation of awake patients. Clinical Neurophysiology 120:11, 1941-1948
    CrossRef

  48. 48

    B. Jarraya, S. Boulet, G. Scott Ralph, C. Jan, G. Bonvento, M. Azzouz, J. E. Miskin, M. Shin, T. Delzescaux, X. Drouot, A.-S. Herard, D. M. Day, E. Brouillet, S. M. Kingsman, P. Hantraye, K. A. Mitrophanous, N. D. Mazarakis, S. Palfi. (2009) Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia. Science Translational Medicine 1:2, 2ra4-2ra4
    CrossRef

  49. 49

    Juan Carlos Gómez-Esteban, Beatriz Tijero, Johanne Somme, Iker Bilbao, Julen Fernández, Sabas Boyero, Fernando Velasco, Elena Lezcano, J.J. Zarranz. (2009) Application of depression criteria (DSM-IV) in patients with Parkinson's disease. Clinical Neurology and Neurosurgery 111:8, 665-669
    CrossRef

  50. 50

    Y. Temel, S. Tan, V. Visser-Vandewalle, T. Sharp. (2009) Parkinson's disease, DBS and suicide: a role for serotonin?. Brain 132:10, e126-e126
    CrossRef

  51. 51

    Adam Zaidel, Alexander Spivak, Lavi Shpigelman, Hagai Bergman, Zvi Israel. (2009) Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov Model. Movement Disorders 24:12, 1785-1793
    CrossRef

  52. 52

    J. Féger, Y. Worbe, L. Galineau, L. Tremblay. (2009) Troubles psychiatriques et ganglions de la base : une validation expérimentale. Annales Pharmaceutiques Françaises 67:5, 320-334
    CrossRef

  53. 53

    Gul Yalcin Cakmakli, Hakan Oruckaptan, Esen Saka, Bulent Elibol. (2009) Reversible acute cognitive dysfunction induced by bilateral STN stimulation. Journal of Neurology 256:8, 1360-1362
    CrossRef

  54. 54

    C. C. M. Poon, M. G. Irwin. (2009) Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices. British Journal of Anaesthesia 103:2, 152-165
    CrossRef

  55. 55

    M. Arends, H. Fangerau, G. Winterer. (2009) „Psychochirurgie“ und tiefe Hirnstimulation mit psychiatrischer Indikation. Der Nervenarzt 80:7, 781-788
    CrossRef

  56. 56

    Daniel D Truong, Erik C Wolters. (2009) Recognition and management of Parkinson’s disease during the premotor (prodromal) phase. Expert Review of Neurotherapeutics 9:6, 847-857
    CrossRef

  57. 57

    S. J. Tye, M. A. Frye, K. H. Lee. (2009) Disrupting Disordered Neurocircuitry: Treating Refractory Psychiatric Illness With Neuromodulation. Mayo Clinic Proceedings 84:6, 522-532
    CrossRef

  58. 58

    P. S. Duggan, A. W. Siegel, D. M. Blass, H. Bok, J. T. Coyle, R. Faden, J. Finkel, J. D. Gearhart, H. T. Greely, A. Hillis, A. Hoke, R. Johnson, M. Johnston, J. Kahn, D. Kerr, P. King, J. Kurtzberg, S. M. Liao, J. W. McDonald, G. McKhann, K. B. Nelson, M. Rao, A. Regenberg, K. Smith, D. Solter, H. Song, J. Sugarman, R. J. Traystman, A. Vescovi, J. Yanofski, W. Young, D. J. H. Mathews. (2009) Unintended Changes in Cognition, Mood, and Behavior Arising from Cell-Based Interventions for Neurological Conditions: Ethical Challenges. The American Journal of Bioethics 9:5, 31-36
    CrossRef

  59. 59

    Michael S. Okun, Hubert H. Fernandez, Samuel S. Wu, Lindsey Kirsch-Darrow, Dawn Bowers, Frank Bova, Michele Suelter, Charles E. Jacobson, Xinping Wang, Clifford W. Gordon, Pam Zeilman, Janet Romrell, Pam Martin, Herbert Ward, Ramon L. Rodriguez, Kelly D. Foote. (2009) Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial. Annals of Neurology 65:5, 586-595
    CrossRef

  60. 60

    T. D. Hälbig, W. Tse, P. G. Frisina, B. R. Baker, E. Hollander, H. Shapiro, M. Tagliati, W. C. Koller, C. W. Olanow. (2009) Subthalamic deep brain stimulation and impulse control in Parkinson’s disease. European Journal of Neurology 16:4, 493-497
    CrossRef

  61. 61

    Georg Juckel, Idun Uhl, Frank Padberg, Martin Brüne, Christine Winter. (2009) Psychosurgery and deep brain stimulation as ultima ratio treatment for refractory depression. European Archives of Psychiatry and Clinical Neuroscience 259:1, 1-7
    CrossRef

  62. 62

    Alim Louis Benabid, Stephan Chabardes, John Mitrofanis, Pierre Pollak. (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. The Lancet Neurology 8:1, 67-81
    CrossRef

  63. 63

    Perminder S Sachdev, Xiaohua Chen. (2009) Neurosurgical treatment of mood disorders: traditional psychosurgery and the advent of deep brain stimulation. Current Opinion in Psychiatry 22:1, 25-31
    CrossRef

  64. 64

    Tanya Simuni, Kapil Sethi. (2008) Nonmotor manifestations of Parkinson's disease. Annals of Neurology 64:S2, S65-S80
    CrossRef

  65. 65

    N. Chastan, G. W. M. Westby, J. Yelnik, E. Bardinet, M. C. Do, Y. Agid, M. L. Welter. (2008) Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease. Brain 132:1, 172-184
    CrossRef

  66. 66

    Giorgio Tommasi, Michele Lanotte, Umberto Albert, Maurizio Zibetti, Lorys Castelli, Giuseppe Maina, Leonardo Lopiano. (2008) Transient acute depressive state induced by subthalamic region stimulation. Journal of the Neurological Sciences 273:1-2, 135-138
    CrossRef

  67. 67

    Claudio N. Soares, Brian J. Murray. (2008) Sleep Disturbances in Women: Psychiatric Considerations. Sleep Medicine Clinics 3:2, 295-306
    CrossRef

  68. 68

    Ho-Ling Liu, Hsin-Mei Chen, Yu-Chien Wu, Siew-Na Lim, Chih-Mao Huang, Yuan-Yu Hsu, Yau-Yau Wai, Tony Wu. (2008) False-positive analysis of functional MRI during simulated deep brain stimulation: A phantom study. Journal of Magnetic Resonance Imaging 27:6, 1439-1442
    CrossRef

  69. 69

    Samuel Bailine, Neil Kremen, Izchak Kohen, Howard Linder, Guy J. Schwartz, Alon Y. Mogilner, Michael Pourfar. (2008) Bitemporal Electroconvulsive Therapy for Depression in a Parkinson Disease Patient With a Deep-Brain Stimulator. The Journal of ECT 24:2, 171-172
    CrossRef

  70. 70

    Jaak Panksepp. 2008. Affective-Social Neuroscience Approaches to Understanding Core Emotional Feelings in Animals. , 57-75.
    CrossRef

  71. 71

    Patric Blomstedt, Marwan I. Hariz, Andrew Lees, Paul Silberstein, Patricia Limousin, Jérôme Yelnik, Yves Agid. (2008) Acute severe depression induced by intraoperative stimulation of the substantia nigra: A case report. Parkinsonism & Related Disorders 14:3, 253-256
    CrossRef

  72. 72

    Matthew D. Johnson, Svjetlana Miocinovic, Cameron C. McIntyre, Jerrold L. Vitek. (2008) Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics 5:2, 294-308
    CrossRef

  73. 73

    Marwan I. Hariz, Stig Rehncrona, Niall P. Quinn, Johannes D. Speelman, Carin Wensing, . (2008) Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years. Movement Disorders 23:3, 416-421
    CrossRef

  74. 74

    Kapil Sethi. (2008) Levodopa unresponsive symptoms in Parkinson disease. Movement Disorders 23:S3, S521-S533
    CrossRef

  75. 75

    Sylvie Piacentini, Luigi Romito, Angelo Franzini, Alberto Granato, Giovanni Broggi, Alberto Albanese. (2008) Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode. Movement Disorders 23:1, 147-150
    CrossRef

  76. 76

    Brian Harris Kopell, Benjamin D. Greenberg. (2008) Anatomy and physiology of the basal ganglia: Implications for DBS in psychiatry. Neuroscience & Biobehavioral Reviews 32:3, 408-422
    CrossRef

  77. 77

    Marco Onofrj, Astrid Thomas, Laura Bonanni. (2007) New approaches to understanding hallucinations in Parkinson’s disease: phenomenology and possible origins. Expert Review of Neurotherapeutics 7:12, 1731-1750
    CrossRef

  78. 78

    Morten L Kringelbach, Sarah LF Owen, Tipu Z Aziz. (2007) Deep-brain stimulation. Future Neurology 2:6, 633-646
    CrossRef

  79. 79

    Y. Temel, L. J. Boothman, A. Blokland, P. J. Magill, H. W. M. Steinbusch, V. Visser-Vandewalle, T. Sharp. (2007) Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proceedings of the National Academy of Sciences 104:43, 17087-17092
    CrossRef

  80. 80

    Brian S. Appleby, Patrick S. Duggan, Alan Regenberg, Peter V. Rabins. (2007) Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Movement Disorders 22:12, 1722-1728
    CrossRef

  81. 81

    Kerry J Ressler, Helen S Mayberg. (2007) Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience 10:9, 1116-1124
    CrossRef

  82. 82

    Erik Ch Wolters. (2007) Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease. Parkinsonism & Related Disorders 13, S18-S23
    CrossRef

  83. 83

    L. B. Marangell, M. Martinez, R. A. Jurdi, H. Zboyan. (2007) Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatrica Scandinavica 116:3, 174-181
    CrossRef

  84. 84

    Werner Poewe. (2007) Depression in Parkinson's disease. Journal of Neurology 254:S5, 49-55
    CrossRef

  85. 85

    Jaak Panksepp. (2007) Neurologizing the Psychology of Affects: How Appraisal-Based Constructivism and Basic Emotion Theory Can Coexist. Perspectives on Psychological Science 2:3, 281-296
    CrossRef

  86. 86

    Drew S. Kern, Rajeev Kumar. (2007) Deep Brain Stimulation. The Neurologist 13:5, 237-252
    CrossRef

  87. 87

    Melissa Tir, David Devos, Serge Blond, Gustavo Touzet, Nicolas Reyns, Alain Duhamel, Olivier Cottencin, Kathy Dujardin, Fran??ois Cassim, Alain Dest??e, Luc Defebvre, Pierre Krystkowiak. (2007) EXHAUSTIVE, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS. Neurosurgery 61:2, 297-305
    CrossRef

  88. 88

    Morten L. Kringelbach, Ned Jenkinson, Sarah L.F. Owen, Tipu Z. Aziz. (2007) Translational principles of deep brain stimulation. Nature Reviews Neuroscience 8:8, 623-635
    CrossRef

  89. 89

    Lars Wojtecki, Janpeter Nickel, Lars Timmermann, Mohammad Maarouf, Martin Südmeyer, Frank Schneider, Rüdiger J. Seitz, Jürgen Voges, Volker Sturm, Alfons Schnitzler. (2007) Pathological crying induced by deep brain stimulation. Movement Disorders 22:9, 1314-1316
    CrossRef

  90. 90

    Atchar Sudhyadhom, Frank J. Bova, Kelly D. Foote, Christian A. Rosado, Lindsey Kirsch-Darrow, Michael S. Okun. (2007) Limbic, associative, and motor territories within the targets for deep brain stimulation: Potential clinical implications. Current Neurology and Neuroscience Reports 7:4, 278-289
    CrossRef

  91. 91

    Alexandre Berney, Michel Panisset, Abbas F. Sadikot, Alain Ptito, Alain Dagher, Maria Fraraccio, Ghislaine Savard, Marc Pell, Chawki Benkelfat. (2007) Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation. Movement Disorders 22:8, 1093-1096
    CrossRef

  92. 92

    Yacov Balash, Doron Merims, Nir Giladi. (2007) Suicidal thoughts in patients with Parkinson?s disease treated by deep brain stimulation of the subthalamic nuclei: two case reports and review of the literature. Acta Neuropsychiatrica 19:3, 208-210
    CrossRef

  93. 93

    Stamatios N Sotiropoulos, Peter N Steinmetz. (2007) Assessing the direct effects of deep brain stimulation using embedded axon models. Journal of Neural Engineering 4:2, 107-119
    CrossRef

  94. 94

    Naotsugu Tsuchiya, Ralph Adolphs. (2007) Emotion and consciousness. Trends in Cognitive Sciences 11:4, 158-167
    CrossRef

  95. 95

    David E. Hardesty, Harold A. Sackeim. (2007) Deep Brain Stimulation in Movement and Psychiatric Disorders. Biological Psychiatry 61:7, 831-835
    CrossRef

  96. 96

    Claudio N. Soares, Brian J. Murray. (2006) Sleep Disorders in Women: Clinical Evidence and Treatment Strategies. Psychiatric Clinics of North America 29:4, 1095-1113
    CrossRef

  97. 97

    Martin L. Bootin. (2006) Deep Brain Stimulation: Overview And Update. Journal of Clinical Monitoring and Computing 20:5, 341-346
    CrossRef

  98. 98

    Rick C. Helmich, Hartwig R. Siebner, Maaike Bakker, Alexander Münchau, Bastiaan R. Bloem. (2006) Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease. Journal of the Neurological Sciences 248:1-2, 84-96
    CrossRef

  99. 99

    Abraham Lieberman. (2006) Are dementia and depression in Parkinson's disease related?. Journal of the Neurological Sciences 248:1-2, 138-142
    CrossRef

  100. 100

    K. Kalteis, H. Standhardt, I. Kryspin-Exner, T. Brücke, D. Volc, F. Alesch. (2006) Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson’s disease. Journal of Neural Transmission 113:9, 1191-1206
    CrossRef

  101. 101

    T. S. Mandat, T. Hurwitz, C. R. Honey. (2006) Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochirurgica 148:8, 895-898
    CrossRef

  102. 102

    David M.B. Christmas, Stephen Curran, Keith Matthews, Muftah S. Eljamel. (2006) Neurosurgery for mental disorder, vagus nerve stimulation and deep brain stimulation. Psychiatry 5:6, 212-216
    CrossRef

  103. 103

    Yasin Temel, Alfons Kessels, Sonny Tan, Alim Topdag, Peter Boon, Veerle Visser-Vandewalle. (2006) Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: A systematic review. Parkinsonism & Related Disorders 12:5, 265-272
    CrossRef

  104. 104

    Valerie Voon, Cynthia Kubu, Paul Krack, Jean-Luc Houeto, Alexander I. Tröster. (2006) Deep brain stimulation: Neuropsychological and neuropsychiatric issues. Movement Disorders 21:S14, S305-S327
    CrossRef

  105. 105

    Guido Gainotti. (2006) Brain lesions and emotional disorders. Future Neurology 1:3, 323-334
    CrossRef

  106. 106

    Daniel Tranel, Greg Gullickson, Margaret Koch, Ralph Adolphs. (2006) Altered experience of emotion following bilateral amygdala damage. Cognitive Neuropsychiatry 11:3, 219-232
    CrossRef

  107. 107

    Kazumichi Yamada, Satoshi Goto, Kazuhito Matsuzaki, Shinji Nagahiro, Nagako Murase, Hideki Shimazu, Ryuji Kaji, Jun-ichi Kuratsu, Yukitaka Ushio. (2006) Psychiatric Symptoms and Subthalamic Nucleus Stimulation in Parkinson's Disease. A Retrospective Study in Our Japanese Patients. Neuromodulation: Technology at the Neural Interface 9:2, 107-114
    CrossRef

  108. 108

    J. Yelnik. (2006) Anatomie structurale et fonctionnelle des ganglions de la base. L'Encéphale 32:2, 3-9
    CrossRef

  109. 109

    L. Mallet. (2006) La stimulation cérébrale profonde : un outil pour la modulation thérapeutique du comportement et des émotions. L'Encéphale 32:2, 44-47
    CrossRef

  110. 110

    Jeffrey Burgdorf, Jaak Panksepp. (2006) The neurobiology of positive emotions. Neuroscience & Biobehavioral Reviews 30:2, 173-187
    CrossRef

  111. 111

    Paul E. Holtzheimer, Charles B. Nemeroff. (2006) Advances in the treatment of depression. NeuroRX 3:1, 42-56
    CrossRef

  112. 112

    A. Lieberman. (2006) Depression in Parkinson's disease - a review. Acta Neurologica Scandinavica 113:1, 1-8
    CrossRef

  113. 113

    Michele Lanotte, Leonardo Lopiano, Elena Torre, Bruno Bergamasco, Luana Colloca, Fabrizio Benedetti. (2005) Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain, Behavior, and Immunity 19:6, 500-509
    CrossRef

  114. 114

    Thomas E Schlaepfer, Klaus Lieb. (2005) Deep brain stimulation for treatment of refractory depression. The Lancet 366:9495, 1420-1422
    CrossRef

  115. 115

    Fabrizio Stocchi. (2005) Pathological gambling in Parkinson's disease. The Lancet Neurology 4:10, 590-592
    CrossRef

  116. 116

    Kelvin L. Chou, Howard I. Hurtig, Jurg L. Jaggi, Gordon H. Baltuch, Rodney J. Pelchat, Daniel Weintraub. (2005) Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism & Related Disorders 11:6, 403-406
    CrossRef

  117. 117

    Yasin Temel, Arjan Blokland, Harry W.M. Steinbusch, Veerle Visser-Vandewalle. (2005) The functional role of the subthalamic nucleus in cognitive and limbic circuits. Progress in Neurobiology 76:6, 393-413
    CrossRef

  118. 118

    Shinichiro Takeshita, Kaoru Kurisu, Liat Trop, Kazunori Arita, Tomohide Akimitsu, Nicolaas Paul L. G. Verhoeff. (2005) Effect of subthalamic stimulation on mood state in Parkinson’s disease: evaluation of previous facts and problems. Neurosurgical Review 28:3, 179-186
    CrossRef

  119. 119

    George A. Mashour, Erin E. Walker, Robert L. Martuza. (2005) Psychosurgery: past, present, and future. Brain Research Reviews 48:3, 409-419
    CrossRef

  120. 120

    Stylianos Nicolaidis. (2005) Depression and neurosurgery: past, present, and future. Metabolism 54:5, 28-32
    CrossRef

  121. 121

    Jasmine M. Henderson, Davor Stanic, Doris Tomas, Justin Patch, Malcolm K. Horne, Darren Bourke, David I. Finkelstein. (2005) Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys. Behavioural Brain Research 160:2, 267-276
    CrossRef

  122. 122

    Yasin Temel, Veerle Visser-Vandewalle, Brenda Aendekerk, Bart Rutten, Sonny Tan, Bart Scholtissen, Christoph Schmitz, Arjan Blokland, Harry W.M. Steinbusch. (2005) Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Experimental Neurology 193:1, 43-52
    CrossRef

  123. 123

    Zeina N. Chemali. (2005) The Essentials of Neuropsychiatry: Teaching Residents and Fellows the Interface Between Psychiatry and Neurology. Harvard Review of Psychiatry 13:5, 312-315
    CrossRef

  124. 124

    Marianna Capecci, Luca Passamonti, Ferdinanda Annesi, Grazia Annesi, Michele Bellesi, Innocenza Claudia Cir Candiano, Riccardo Ricciuti, Maurizio Iacoangeli, Massimo Scerrati, Mario Zappia, Patrizia Tarantino, Elvira Valeria De Marco, Donatella Civitelli, Sara Carrideo, Leandro Provinciali, Maria Gabriella Ceravolo, Aldo Quattrone. (2004) Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the Parkin gene. Movement Disorders 19:12, 1450-1452
    CrossRef

  125. 125

    Xavier Drouot, Satoru Oshino, Bechir Jarraya, Laurent Besret, Haruhiko Kishima, Philippe Remy, Julien Dauguet, Jean Pascal Lefaucheur, Frédéric Dollé, Françoise Condé, Michel Bottlaender, Marc Peschanski, Yves Kéravel, Philippe Hantraye, Stéphane Palfi. (2004) Functional Recovery in a Primate Model of Parkinson's Disease following Motor Cortex Stimulation. Neuron 44:5, 769-778
    CrossRef

  126. 126

    Luana Colloca, Leonardo Lopiano, Michele Lanotte, Fabrizio Benedetti. (2004) Overt versus covert treatment for pain, anxiety, and Parkinson's disease. The Lancet Neurology 3:11, 679-684
    CrossRef

  127. 127

    Andres M. Kanner. (2004) Is major depression a neurologic disorder with psychiatric symptoms?. Epilepsy & Behavior 5:5, 636-644
    CrossRef

  128. 128

    M Sensi, R Eleopra, M.A Cavallo, E Sette, P Milani, R Quatrale, J.G Capone, V Tugnoli, M.R Tola, E Granieri, P.G Data. (2004) Explosive-aggressive behavior related to bilateral subthalamic stimulation. Parkinsonism & Related Disorders 10:4, 247-251
    CrossRef

  129. 129

    Lieve Desbonnet, Yasin Temel, Veerle Visser-Vandewalle, Arjan Blokland, Veronique Hornikx, Harry W.M Steinbusch. (2004) Premature responding following bilateral stimulation of the rat subthalamic nucleus is amplitude and frequency dependent. Brain Research 1008:2, 198-204
    CrossRef

  130. 130

    Robert E Gross. (2004) Deep brain stimulation in the treatment of neurological and psychiatric disease. Expert Review of Neurotherapeutics 4:3, 465-478
    CrossRef

  131. 131

    Fabrizio Benedetti, Luana Colloca, Michele Lanotte, Bruno Bergamasco, Elena Torre, Leonardo Lopiano. (2004) Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Research Bulletin 63:3, 203-211
    CrossRef

  132. 132

    John S. Price, Russell Gardner, Mark Erickson. (2004) Can depression, anxiety and somatization be understood as appeasement displays?. Journal of Affective Disorders 79:1-3, 1-11
    CrossRef

  133. 133

    Martin Krause, Wolfgang Fogel, Petra Mayer, Manja Kloss, Volker Tronnier. (2004) Chronic inhibition of the subthalamic nucleus in Parkinson's disease. Journal of the Neurological Sciences 219:1-2, 119-124
    CrossRef

  134. 134

    Ruediger Hilker, Juergen Voges, Simon Weisenbach, Elke Kalbe, Lothar Burghaus, Mehran Ghaemi, Ralph Lehrke, Athanasios Koulousakis, Karl Herholz, Volker Sturm, Wolf-Dieter Heiss. (2004) Subthalamic Nucleus Stimulation Restores Glucose Metabolism in Associative and Limbic Cortices and in Cerebellum: Evidence from a FDG-PET Study in Advanced Parkinson's Disease. Journal of Cerebral Blood Flow & Metabolism7-16
    CrossRef

  135. 135

    P. Francel, K. Ryder, J. Wetmore, A. Stevens, K. Bharucha, W.W. Beatty, J. Scott. (2004) Deep Brain Stimulation for Parkinson’s Disease: Association between Stimulation Parameters and Cognitive Performance. Stereotactic and Functional Neurosurgery 82:4, 191-193
    CrossRef

  136. 136

    Taresa Stefurak, David Mikulis, Helen Mayberg, Anthony E. Lang, Stephanie Hevenor, Peter Pahapill, Jean Saint-Cyr, Andres Lozano. (2003) Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study. Movement Disorders 18:12, 1508-1516
    CrossRef

  137. 137

    Alim Louis Benabid. (2003) Deep brain stimulation for Parkinson’s disease. Current Opinion in Neurobiology 13:6, 696-706
    CrossRef

  138. 138

    Laura S. Boylan, Thomas J. Kaley, Anuradha Singh, Orrin Devinsky. (2003) Postictal laughter following absence status epilepticus. Epilepsy & Behavior 4:6, 773-775
    CrossRef

  139. 139

    Ray M. Chu, Ramachandra P. Tummala, Walter A. Hall. (2003) Intraoperative Magnetic Resonance Imaging-Guided Neurosurgery. Neurosurgery Quarterly 13:4, 234-250
    CrossRef

  140. 140

    Alessandra Pesenti, Alberto Priori, Marco Locatelli, Marcello Egidi, Paolo Rampini, Filippo Tamma, Elena Caputo, Valentina Chiesa, Sergio Barbieri. (2003) Subthalamic somatosensory evoked potentials in Parkinson's disease. Movement Disorders 18:11, 1341-1345
    CrossRef

  141. 141

    Dominique Guehl, Francois Tison, Emmanuel Cuny, Abdelhamid Benazzouz, Alain Rougier, Bernard Bioulac, Pierre Burbaud. (2003) Complications and adverse effects of deep brain stimulation in Parkinson’s patients. Expert Review of Neurotherapeutics 3:6, 811-819
    CrossRef

  142. 142

    Ellen Stover, Wayne Fenton, Anne Rosenfeld, Thomas R Insel. (2003) Depression and comorbid medical illness: the National Institute of Mental Health perspective. Biological Psychiatry 54:3, 184-186
    CrossRef

  143. 143

    William M McDonald, Irene H Richard, Mahlon R DeLong. (2003) Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biological Psychiatry 54:3, 363-375
    CrossRef

  144. 144

    Karen E. Anderson, Jake Mullins. (2003) Behavioral changes associated with deep brain stimulation surgery for Parkinson’s disease. Current Neurology and Neuroscience Reports 3:4, 306-313
    CrossRef

  145. 145

    Aurlie Funkiewiez, Claire Ardouin, Paul Krack, Valrie Fraix, Nadge Van Blercom, Jing Xie, Elena Moro, Alim-Louis Benabid, Pierre Pollak. (2003) Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Movement Disorders 18:5, 524-530
    CrossRef

  146. 146

    Helen Bronte-Stewart. (2003) Parkinson’s disease: Surgical options. Current Treatment Options in Neurology 5:2, 131-147
    CrossRef

  147. 147

    J FINS. (2003) From psychosurgery to neuromodulation and palliation: history's lessons for the ethical conduct and regulation of neuropsychiatric research. Neurosurgery Clinics of North America 14:2, 303-319
    CrossRef

  148. 148

    Laura Marsh, Ariel Berk. (2003) Neuropsychiatric aspects of Parkinson’s disease: Recent advances. Current Psychiatry Reports 5:1, 68-76
    CrossRef

  149. 149

    Jaak Panksepp. (2003) Can anthropomorphic analyses of separation cries in other animals inform us about the emotional nature of social loss in humans? Comment on Blumberg and Sokoloff (2001).. Psychological Review 110:2, 376-388
    CrossRef

  150. 150

    C. W. Olanow. (2002) Surgical therapy for Parkinson's disease. European Journal of Neurology 9:s3, 31-39
    CrossRef

  151. 151

    Luigi Michele Romito, Michele Raja, Antonio Daniele, Maria Fiorella Contarino, Anna Rita Bentivoglio, Annalisa Barbier, Massimo Scerrati, Alberto Albanese. (2002) Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Movement Disorders 17:6, 1371-1374
    CrossRef

  152. 152

    Jean A. Saint-Cyr, Tasnuva Hoque, Luiz C. M. Pereira, Jonathan O. Dostrovsky, William D. Hutchison, David J. Mikulis, Aviva Abosch, Elspeth Sime, Anthony E. Lang, Andres M. Lozano. (2002) Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. Journal of Neurosurgery 97:5, 1152-1166
    CrossRef

  153. 153

    D. J. Burn. (2002) Depression in Parkinson's disease. European Journal of Neurology 9:s3, 44-54
    CrossRef

  154. 154

    Paresh K. Doshi, Niraj Chhaya, Mohit H. Bhatt. (2002) Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Movement Disorders 17:5, 1084-1085
    CrossRef

  155. 155

    Carol A Tamminga, Charles B Nemeroff, Randy D Blakely, Linda Brady, Cameron S Carter, Kenneth L Davis, Raymond Dingledine, Jack M Gorman, Dimitri E Grigoriadis, David C Henderson, Robert B. Innis, John Killen, Thomas P Laughren, William M McDonald, Greer M. Murphy, Steven M Paul, Matthew V Rudorfer, Edward Sausville, Alan F Schatzberg, Edward M Scolnick, Trisha Suppes. (2002) Developing novel treatments for mood disorders: accelerating discovery. Biological Psychiatry 52:6, 589-609
    CrossRef

  156. 156

    Carine Karachi, Chantal Franois, Karine Parain, Eric Bardinet, Dominique Tand, Etienne Hirsch, Jrme Yelnik. (2002) Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. The Journal of Comparative Neurology 450:2, 122-134
    CrossRef

  157. 157

    Philip A. Starr, Chadwick W. Christine, Philip V. Theodosopoulos, Nadja Lindsey, Deborah Byrd, Anthony Mosley, William J. Marks. (2002) Implantation of deep brain stimulators into subthalmic nucleus: technical approach and magnetic imaging—verified electrode locations. Journal of Neurosurgery 97:2, 370-387
    CrossRef

  158. 158

    Carolyn H. Kwak, Joseph Jankovic. (2002) Tourettism and dystonia after subcortical stroke. Movement Disorders 17:4, 821-825
    CrossRef

  159. 159

    A. F. G. Leentjens, F. R. J. Verhey. (2002) Depression and Parkinson's disease: a conceptual challenge. Acta Neuropsychiatrica 14:3, 147-153
    CrossRef

  160. 160

    V. Krauthamer, T. Crosheck. (2002) Effects of high-rate electrical stimulation upon firing in modelled and real neurons. Medical & Biological Engineering & Computing 40:3, 360-366
    CrossRef

  161. 161

    David J. Burn. (2002) Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Movement Disorders 17:3, 445-454
    CrossRef

  162. 162

    Thomas J. Loher, Jean-Marc Burgunder, Thomas Pohle, Sabine Weber, Regine Sommerhalder, Joachim K. Krauss. (2002) Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. Journal of Neurosurgery 96:5, 844-853
    CrossRef

  163. 163

    Pierre Pollak, Valrie Fraix, Paul Krack, Elena Moro, Alexandre Mendes, Stephan Chabardes, Adnan Koudsie, Alim-Louis Benabid. (2002) Treatment results: Parkinson's disease. Movement Disorders 17:S3, S75-S83
    CrossRef

  164. 164

    Paul Krack, Valrie Fraix, Alexandre Mendes, Alim-Louis Benabid, Pierre Pollak. (2002) Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Movement Disorders 17:S3, S188-S197
    CrossRef

  165. 165

    Francesc Valldeoriola, Manuela Pilleri, Eduardo Tolosa, Jos L. Molinuevo, Jordi Rumi, Enric Ferrer. (2002) Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long-term follow-up of patients. Movement Disorders 17:1, 125-132
    CrossRef

  166. 166

    Emmeline Edwards, Cheryl Kitt, Eugene Oliver, Judith Finkelstein, Molly Wagster, William M. McDonald. (2002) Depression and parkinson's disease: a new look at an old problem. Depression and Anxiety 16:1, 39-48
    CrossRef

  167. 167

    Tobias Loddenkemper, Andrew Pan, Silvia Neme, Kenneth B. Baker, Ali R. Rezai, Dudley S. Dinner, Erwin B. Montgomery, Hans O. L??ders. (2001) Deep Brain Stimulation in Epilepsy. Journal of Clinical Neurophysiology 18:6, 514-532
    CrossRef

  168. 168

    William J Marks, Jr.. (2001) Surgical treatment of Parkinson’s disease: ablation, stimulation and transplantation. Expert Review of Neurotherapeutics 1:2, 239-246
    CrossRef

  169. 169

    Robert M. Roth, Laura A. Flashman, Andrew J. Saykin, David W. Roberts. (2001) Deep brain stimulation in neuropsychiatric disorders. Current Psychiatry Reports 3:5, 366-372
    CrossRef

  170. 170

    Paul Krack, Rajeev Kumar, Claire Ardouin, Patricia Limousin Dowsey, John M. McVicker, Alim-Louis Benabid, Pierre Pollak. (2001) Mirthful laughter induced by subthalamic nucleus stimulation. Movement Disorders 16:5, 867-875
    CrossRef

  171. 171

    John Hammerstad, Penelope Hogarth. (2001) Parkinson’s disease: Surgical options. Current Neurology and Neuroscience Reports 1:4, 313-319
    CrossRef

  172. 172

    Lauren B. Marangell, A.John Rush, Mark S. George, Danae Georges, Harold A. Sackeim. (2001) A Review of Vagus Nerve Stimulation for Treatment-Resistant Depression. Epilepsy & Behavior 2:3, S6-S10
    CrossRef

  173. 173

    Roger M Pinder. (2001) On the feasibility of designing new antidepressants. Human Psychopharmacology: Clinical and Experimental 16:1, 53-59
    CrossRef

  174. 174

    M GEORGE. (2000) VAGUS NERVE STIMULATIONA Potential Therapy for Resistant Depression?. Psychiatric Clinics of North America 23:4, 757-783
    CrossRef

  175. 175

    Philip A. Starr, Thyagarajan Subramanian, Roy A. E. Bakay, Thomas Wichmann. (2000) Electrophysiological localization of the substantia nigra in the parkinsonian nonhuman primate. Journal of Neurosurgery 93:4, 704-710
    CrossRef

  176. 176

    Abhijit Chaudhuri, Peter O Behan. (2000) Fatigue and basal ganglia. Journal of the Neurological Sciences 179:1-2, 34-42
    CrossRef

  177. 177

    Nico J. Diederich, Fran[ccedil]ois Alesch, Christopher G. Goetz. (2000) Visual Hallucinations Induced by Deep Brain Stimulation in Parkinson's Disease. Clinical Neuropharmacology 23:5, 287-289
    CrossRef

  178. 178

    Jean A. Saint-Cyr, Lisa L. Trpanier. (2000) Neuropsychologic assessment of patients for movement disorder surgery. Movement Disorders 15:5, 771-783
    CrossRef

  179. 179

    Theresa A. Zesiewicz, Robert A. Hauser. (2000) Depression in Patients with Parkinson??s Disease. CNS Drugs 13:4, 253-264
    CrossRef

  180. 180

    Steven M. Miller, Guang B. Liu, Trung T. Ngo, Greg Hooper, Stephan Riek, Richard G. Carson, John D. Pettigrew. (2000) Interhemispheric switching mediates perceptual rivalry. Current Biology 10:7, 383-392
    CrossRef

  181. 181

    Mark S. George, Harold A. Sackeim, A.John Rush, Lauren B. Marangell, Ziad Nahas, Mustafa M. Husain, Sarah Lisanby, Tal Burt, Juliet Goldman, James C. Ballenger. (2000) Vagus nerve stimulation: a new tool for brain research and therapy. Biological Psychiatry 47:4, 287-295
    CrossRef

  182. 182

    Mark H. Corrigan, Angelita Q. Denahan, C. Eugene Wright, Rhonda J. Ragual, Dwight L. Evans. (2000) Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depression and Anxiety 11:2, 58-65
    CrossRef

  183. 183

    Yves Agid. (1999) Continuous high frequency stimulation of deep brain structures in brain pathology. Brain Research Bulletin 50:5-6, 475
    CrossRef

  184. 184

    (1999) Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation. New England Journal of Medicine 341:13, 1003-1004
    Full Text

  185. 185

    Paul Krack, Wolfgang Hamel, Hubertus Maximilian Mehdorn, Günther Deuschl. (1999) Surgical treatment of Parkinsonʼs disease. Current Opinion in Neurology 12:4, 417-425
    CrossRef

  186. 186

    Dag Aarsland, Karen Karlsen. (1999) Neuropsychiatric aspects of parkinson’s disease. Current Psychiatry Reports 1:1, 61-68
    CrossRef

  187. 187

    Yudofsky, Stuart C., . (1999) Parkinson's Disease, Depression, and Electrical Stimulation of the Brain. New England Journal of Medicine 340:19, 1500-1502
    Full Text

Letters